EZR and lung carcinoma: Ezrin is mainly distributed in lung cancer tissues and metastases, and its expression is significantly correlated with the degree of lymphatic metastasis, malignant phenotype, and advanced TNM stage in patients with lung cancer, while downregulating Ezrin protein can reverse lung cancer malignant behavior [24].